SCHEMBL18756137

SCHEMBL18756137

CC(=O)c1cc(Cc2ccc(-c3cn(C)nc3C)cc2)c(C)cn1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.39
▸ CHRM1 P11229 9/20 0.39
▸ AXL P30530 1/20 0.39
▸ MERTK Q12866 1/20 0.39
▸ PDE2A O00408 1/20 0.38
▸ PDE11A Q9HCR9 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ WDR77 Q9BQA1 1/20 0.38
▸ MAPK1 P28482 5/20 0.37
▸ KCNH2 Q12809 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ CREBBP Q92793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17440089 0.91 AXL (0.40) USP30CHRM1AXLMERTKPDE2A
SCHEMBL18725472 0.88 AXL (0.41) USP30CHRM1AXLMERTKPDE2A
SCHEMBL17440098 0.87 GABRP (0.42) USP30CHRM1AXLMERTKPDE2A
SCHEMBL18725478 0.80 CHRM1 (0.64) CHRM1AXLMERTKPDE2APDE11A
SCHEMBL18725408 0.79 CHRM1 (0.66) CHRM1AXLMERTKPDE2APDE11A
Hydrochloric Acid SCHEMBL18725413 0.79 CHRM1 (0.63) CHRM1AXLMERTKPDE2APDE11A
SCHEMBL18756656 0.79 CHRM1 (0.44) USP30CHRM1AXLMERTKPDE2A
SCHEMBL17449677 0.77 CHRM1 (0.70) CHRM1PDE2APDE11A
SCHEMBL17440017 0.77 CHRM1 (0.70) CHRM1PDE2APDE11A
SCHEMBL17443033 0.77 CHRM1 (0.56) USP30CHRM1AXLMERTKPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3156397-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2019-08-07 — — EP disclosed
EP-3156397-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-04-19 — — EP disclosed
Send feedback